Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study

被引:0
|
作者
Shadman, Mazyar [1 ]
Sail, Kavita [2 ]
Manzoor, Beenish S. [2 ]
Yazdy, Maryam Sarraf [3 ]
Hill, Brian T. [4 ]
Tuncer, Hande H. [5 ]
Allan, John N. [6 ]
Ujjani, Chaitra S. [1 ]
Emechebe, Nnadozie [2 ]
Kamalakar, Rajesh [2 ]
Sharmokh, Simon [2 ]
Jiang, Daniel Dingfeng [2 ]
Pena, German [2 ]
Marshall, Thomas [2 ]
Nielsen, Jacqueline [2 ]
Barr, Paul M. [7 ]
Brown, Jennifer R. [8 ]
Schuh, Anna [9 ]
Eyre, Toby A. [9 ]
Lamanna, Nicole [10 ]
Wierda, William G. [11 ]
Skarbnik, Alan [12 ]
Roeker, Lindsey E. [13 ]
Bannerji, Rajat [14 ]
Pauff, James M. [2 ]
Schuster, Stephen J. [15 ]
Follows, George A. [16 ]
Cheson, Bruce D. [17 ]
Eichhorst, Barbara F. [18 ]
Brander, Danielle M. [19 ]
Pivneva, Irina [20 ]
Guerin, Annie [20 ]
Mato, Anthony R. [13 ,21 ]
机构
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] AbbVie Inc, N Chicago, IL USA
[3] Georgetown Univ Hosp, Washington, DC 20007 USA
[4] Cleveland Clin, Cleveland, OH 44106 USA
[5] Lowell Gen Hosp, Ctr Canc, Lowell, MA USA
[6] Weill Cornell Med Univ, Med Ctr, New York, NY USA
[7] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA
[8] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[9] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford, England
[10] Columbia Univ, New York, NY USA
[11] MD Anderson Canc Ctr, Houston, TX USA
[12] Novant Hlth, Charlotte, NC USA
[13] Mem Sloan Kettering Canc Ctr, Div Hematol Oncol, CLL Program, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA
[14] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[15] Univ Penn, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[16] Cambridge Univ Hosp NHS Trust, Cambridge, England
[17] Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
[18] Univ Cologne, Dept Internal Med, Ctr Integrated Oncol Koln Bonn, Cologne, Germany
[19] Duke Univ, Med Ctr, Duke Canc Ctr, Durham, NC USA
[20] Anal Grp, Montreal, PQ, Canada
[21] Mem Sloan Kettering Canc Ctr, Hematol Malignancies Div, CLL Program, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
10.1182/blood-2019-131401
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3048
引用
下载
收藏
页数:7
相关论文
共 50 条
  • [41] The safety and efficacy of diclofenac sodium suppository as adjunctive opioids in the treatment of cancer pain: A prospective, multi-center, real-world study
    He, Jianping
    Zhang, Yan
    Wu, Yaogui
    Zhao, Huarong
    Yang, Jinqi
    Zhang, Zhenhua
    Qiao, Hongmei
    Cao, Yufeng
    Yan, Zhenhua
    Wang, Yang
    Ji, Guoyi
    Zhan, Shudong
    Zhang, Yarui
    Sun, Yu
    Meng, Peng
    Zhang, Xiuliang
    Wang, Xiang
    Guo, Zhifeng
    Ren, Shoulei
    Zhang, Wentian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB IN CROHN'S DISEASE: WEEK 52 RESULTS FROM THE SWEDISH MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL SVEAH CD STUDY
    Eriksson, Carl
    Rundquist, Sara
    Lykiardopoulos, Byron
    Udumyan, Ruzan
    Karlen, Per
    Grip, Olof
    Soderman, Charlotte
    Almer, Sven
    Hertervig, Erik
    Gunnarsson, Jenny
    Malmgren, Carolina
    Delin, Jenny
    Strid, Hans
    Sjoberg, Mats
    Oberg, David
    Daniel, Bergemalm
    Hjortswang, Henrik
    Halfvarson, Jonas
    GASTROENTEROLOGY, 2020, 158 (06) : S963 - S963
  • [43] The efficacy and tolerability of adjunctive brivaracetam for the treatment of adult epilepsy: An Australian multi-center retrospective real-world observational cohort study
    Halliday, Amy J.
    Vogrin, Sara
    Ignatiadis, Sophia
    Gillinder, Lisa
    Jones, Dean
    Kiley, Michelle
    Kwan, Patrick
    Seneviratne, Udaya
    Somerville, Ernest
    Whitham, Emma
    Nikpour, Armin
    Lawn, Nicholas
    D'Souza, Wendyl J.
    EPILEPSY & BEHAVIOR, 2023, 145
  • [44] Treatment Patterns Following Abaloparatide Initiation: Data from Real-World Clinical Practice Settings
    Gold, Deborah T.
    Pearman, Leny
    Beckett, Tammy
    Deal, Chad
    Epstein, Robert S.
    James, Andrew L.
    Kernaghan, Jacqueline M.
    Mohseni, Mahshid
    Spiegel, Michael
    Vokes, Tamara
    McMillan, Abigail
    Bailey, Tom
    Wang, Yamei
    Williams, Setareh A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 310 - 310
  • [45] Largest Real-World Multi-Center Study Outcomes Reported with Controlled Hypothermic Preservation of Donor Lungs
    Haney, J.
    Hartwig, M.
    Langer, N.
    Sanchez, P.
    Carrott, P.
    Huang, H.
    Ceulemans, L.
    Kukreja, J.
    Bush, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S19 - S20
  • [46] REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Choi, J.
    Sreih, A.
    Lehman, T.
    Suryavanshi, M.
    Xia, Q.
    Nowak, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1564 - 1565
  • [47] Utility and optimal management of planned drug holidays during lenvatinib treatment in patients with unresectable differentiated thyroid cancer: a real-world multi-center study
    Mikoshiba, Takuya
    Sekimizu, Mariko
    Kono, Takeyuki
    Nagai, Ryoto
    Kawasaki, Taiji
    Sato, Yoichiro
    Ito, Fumihiro
    Nakahara, Nana
    Shigetomi, Seiji
    Ozawa, Hiroyuki
    ENDOCRINE, 2024, 85 (02) : 777 - 785
  • [48] Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis
    Xu, Yuan
    Wang, Ying
    Wu, Runhui
    Zheng, Changcheng
    Xiao, Jianwen
    Xu, Weiqun
    Feng, Xiaoqin
    Wang, Hua
    Cao, Xiangshan
    He, Liya
    Xue, Tianyang
    Jin, Mingwei
    Xie, Bingshou
    Ling, Jing
    Sun, Lirong
    Su, Rui
    Cheng, Hongbo
    Fang, Yongjun
    Li, Bai
    Yu, Ziqiang
    Xue, Ailing
    Sun, Mei
    Yang, Li
    Zhou, Zeping
    Zhou, Hu
    Jin, Jiao
    Zhou, Min
    Chen, Rong
    Liu, Wei
    Zhang, Lei
    Xue, Feng
    Yang, Renchi
    BLOOD, 2023, 142
  • [49] THE VALUE OF RITUXIMAB ADDITION TO CHEMOTHERAPY TREATMENT OF REAL-WORLD CLL PATIENTS: A 15 YEAR SINGLE CENTER EXPERIENCE
    Van der Straten, L.
    Dinmohamed, A. G.
    Doorduijn, J. K.
    Westerweel, P. E.
    Langerak, A. W.
    Kater, A. P.
    Levin, M. -D.
    HAEMATOLOGICA, 2017, 102 : 721 - 721
  • [50] Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in CLL: Results from a Large Multi-Center Study of 683 US-Patients
    Mato, Anthony R.
    Hill, Brian T.
    Lamanna, Nicole
    Barr, Paul
    Ujjani, Chaitra S.
    Brander, Danielle M.
    Howlett, Christina
    Skarbnik, Alan P.
    Cheson, Bruce
    Zent, Clive S.
    Pu, Jeffrey J.
    Kiselev, Pavel
    Bachow, Spencer Henick
    Winter, Allison M.
    Cruz, Allan-Louie
    Claxton, David F.
    Daniel, Catherine
    Isaack, Krista
    Kennard, Kaitlin H.
    Timlin, Colleen
    Fanning, Molly
    Yacur, Melissa
    Svoboda, Jakub
    Schuster, Stephen J.
    Nabhan, Chadi
    BLOOD, 2016, 128 (22)